Gilead Sciences Inc. (GILD)

Index:

Nasdaq 100

$ 124.70
   
  • Change Today:
    $-0.97
  • 52 Week High: $128.07
  • 52 Week Low: $89.14
  • Currency: US Dollars
  • Shares Issued: 1,246.00m
  • Volume: 2,073,803
  • Market Cap: $155,376m
  • RiskGrade: 120

Latest ShareCast News

GSK's ViiV says trial indicates HIV shot as effective as rival Gilead pill

By Frank Prenesti

Date: Thursday 23 Feb 2023

(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GILD Market Data

Currency US Dollars
Share Price $ 124.70
Change Today $ -0.97
% Change -0.77 %
52 Week High $128.07
52 Week Low $89.14
Volume 2,073,803
Shares Issued 1,246.00m
Market Cap $155,376m
RiskGrade 120

What The Brokers Say

Strong Buy 9
Buy 13
Neutral 6
Sell 1
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 26-Dec-2025

Time Volume / Share Price
15:59 1,094 @ $124.69
15:59 123 @ $124.70
15:59 107 @ $124.70
15:59 100 @ $124.71
15:59 100 @ $124.69

Top of Page